ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 2790

The Research In Arthritis In Canadian Children Emphasizing Outcomes (ReACCh Out) Cohort:  Are We Achieving Clinically Important Outcomes?

Deborah M. Levy1, Shirley ML Tse1, Elizabeth Stringer2, Jaime Guzman3, Roberta A. Berard4, Karen Watanabe Duffy5, Dax Rumsey1, Mercedes O. Chan3, Rosie Scuccimarri6, Adam M. Huber7, Lori B. Tucker3, Rae SM Yeung1, Ciaran M. Duffy5, Kiem Oen8 and The ReACCh Out Investigators9, 1Rheumatology, The Hospital for Sick Children and University of Toronto, Toronto, ON, Canada, 2Department of Rheumatology, IWK Health Centre, Halifax, NS, Canada, 3Rheumatology, BC Children's Hospital and University of British Columbia, Vancouver, BC, Canada, 4Children's Hospital of Western Ontario, London, ON, Canada, 5Rheumatology, Children's Hospital of Eastern Ontario and University of Ottawa, Ottawa, ON, Canada, 6McGill University, Montreal, QC, Canada, 7Dalhousie University, Halifax, NS, Canada, 8Pediatrics, Children's Hospital of Winnipeg and University of Manitoba, Winnipeg, MB, Canada, 9The Hospital for Sick Children and University of Toronto, Toronto, ON, Canada

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Disease Activity, Juvenile Arthritis, juvenile idiopathic arthritis (JIA) and juvenile idiopathic arthritis-enthesitis (ERA), Systemic JIA

  • Tweet
  • Email
  • Print
Session Information

Session Title: ACR/ARHP Combined Pediatrics Abstract Session

Session Type: Combined Abstract Sessions

Background/Purpose:  Recent data suggests that achievement of inactive disease and early disease remission may result in improved outcomes for patients with juvenile idiopathic arthritis (JIA).  Objectives of our study were to examine the probabilities of achieving i) active joint count (AJC)= 0; ii) inactive disease; and iii) disease remission for patients treated with contemporary treatments in a large prospective longitudinal inception cohort of patients with JIA.

Methods: ReACCh Out recruited consecutive patients diagnosed with JIA at 16 sites across Canada (Jan 2005 – Dec 2010), with prospective data collection every 6 months for the first 2 years, then yearly.  Clinical information included the six ACR core outcome measures and medications.  Inactive disease was defined as active joint count (AJC) =0, absence of systemic symptoms, enthesitis or uveitis and a physician global activity (PGA) of < 1 cm on a 10 cm VAS.  Remission was defined as ≥ 12 months with inactive disease with no anti-rheumatic or anti-uveitis medications.   Descriptive statistics (median and interquartile range (IQR)) and Kaplan-Meier Survival analyses were examined; patients were censored at their last study visit or study end date.

Results: 1104 patients with newly diagnosed (≤ 6 months) active JIA with ≥1 follow-up visit were analyzed.  Patients were predominantly female (63%), age at diagnosis was 9.3 (3. 9, 13.0) years. Time from diagnosis to enrollment was 0.3 (0, 1.6) months.  Follow-up to last visit or study end was 34.2 (21.5, 48) months. Patients were classified into ILAR subtypes at the 6 month visit:  oligoarticular (416, 38%), polyarticular RF negative (235, 21%), polyarticular RF positive (46, 4%), psoriatic (64, 6%), enthesitis related arthritis (ERA) (157, 14%), systemic (sJIA)(76, 7%) and undifferentiated (110, 10%).  Treatment received included intraarticular steroid injections in 46%, DMARDs in 55%, and biologics in 12%.   Almost all patients (92%) achieved AJC=0 during the study period at a median of 7.0 mos (IQR 3.5, 13.3) from diagnosis.  Patients with RF positive polyarthritis were last to reach AJC =0.  Inactive disease was achieved by 81% of subjects at a median of 13.0 mos (IQR 7.7, 21.7) from diagnosis.  Time to first episode of inactive disease was shortest in the oligoarthritis group, and longest in the RF positive polyarthritis group.  Table 1 shows the time to achieve AJC =0 and inactive disease by JIA subtype.    By survival analysis, the probability of disease remission by 4 years of disease was oligoarthritis (41%), polyarticular RF negative (8%), polyarticular RF positive (0%), psoriatic (47%), ERA (28%), sJIA (29%) and undifferentiated (30%). 

Table 1: Disease duration (in months) to achieve outcomes

 

AJC = 0

Inactive Disease

 

N

Median (IQR)

N

Median (IQR)

Oligoarthritis

412

5.9 (3.3, 10.0)

410

9.6 (6.8, 14.9)

Polyarticular RF negative

235

10.2 (5.0, 16.5)

232

14.9 (10.8, 27.3)

Polyarticular RF positive

46

10.0 (6.7, 20.2)

46

24.2 (13.5, 39.5)

Psoriatic

62

7.2 (4.7, 14.9)

63

12.6 (7.7, 18.1)

Enthesitis Related Arthritis

157

6.8 (3.0, 14.3)

153

16.0 (10.7, 24.5)

Systemic

75

3.6 (2.0, 11.3)

74

13.1 (6.7, 36.4)

Undifferentiated

110

6.4 (3.2, 15.9)

108

14.4 (9.4, 22.7)

Conclusion: Almost all patients achieve an AJC =0, and most attain inactive disease; however, the probability of remission remains low for the polyarticular subtypes.


Disclosure:

D. M. Levy,
None;

S. M. Tse,
None;

E. Stringer,
None;

J. Guzman,
None;

R. A. Berard,
None;

K. Watanabe Duffy,
None;

D. Rumsey,
None;

M. O. Chan,
None;

R. Scuccimarri,
None;

A. M. Huber,
None;

L. B. Tucker,
None;

R. S. Yeung,
None;

C. M. Duffy,
None;

K. Oen,
None;

T. ReACCh Out Investigators,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-research-in-arthritis-in-canadian-children-emphasizing-outcomes-reacch-out-cohort-are-we-achieving-clinically-important-outcomes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2022 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.